4.5 Article

Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry

Journal

VACCINE
Volume 28, Issue 4, Pages 1094-1105

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.10.018

Keywords

Salmonella; Campylobacter; CjaA; Vaccine; Chicken

Funding

  1. Biotechnology and Biological Sciences Research Council
  2. Department for the Environment, Food and Rural Affairs [BB/D000866/1, BB/D00019X/1]
  3. BBSRC [BB/D00019X/1, BB/D000866/1] Funding Source: UKRI
  4. MRC [G0801161] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BB/D000866/1, BB/D00019X/1] Funding Source: researchfish
  6. Medical Research Council [G0801161] Funding Source: researchfish

Ask authors/readers for more resources

Campylobacter jejuni is a zoonotic bacterial pathogen of worldwide importance It is estimated that 460,000 human infections occur in the United Kingdom per annum and these involve acute enteritis and may be complicated by severe systemic sequelae Such infections are frequently associated with the consumption of contaminated poultry meat and strategies to control C jejuni in poultry are expected to limit pathogen entry into the food chain and the incidence of human disease Toward this aim. a total of 840 Light Sussex chickens were used to evaluate a Salmonella enterica serovar Typhimurium Delta aroA vaccine expressing the C jejuni amino acid binding protein CjaA as a plasmid-borne fusion to the C-terminus of fragment C of tetanus toxin Chickens were given the vaccine at I-day-old and two weeks later by oral gavage, then challenged after a further two weeks with C jejuni Across six biological replicates, statistically significant reductions in caecal C jejuni of c 1 4log(10) colony-forming units/g were observed at three and four weeks post-challenge relative to age-matched unvaccinated birds Protection was associated with the induction of CjaA-specific serum IgY and biliary IgA. Protection was not observed using a vaccine strain containing the empty plasmid Vaccination with recombinant CjaA subcutaneously at the same intervals significantly reduced the caecal load of C jejuni at three and four weeks post-challenge Taken together these data imply that responses directed against CjaA, rather than competitive or cross-protective effects mediated by the carrier, confer protection. The impact of varying parameters on the efficacy of the S Typhimurium Delta aroA vaccine expressing TetC-CjaA was also tested Delaying the age at primary vaccination had little impact on protection or humoral responses to CjaA. The use of the parent strain as carrier or changing the attenuating mutation of the carrier to Delta spaS or Delta ssaU enhanced the protective effect, consistent with increased invasion and persistence of the vaccine strains relative to the Delta aroA mutant Expression in the Delta aroA strain of a TetC fusion to Peb1A, but not TetC fusions to GInH or ChuA, elicited protection against intestinal colonisation by C jejuni that was comparable to that observed with the TetC-CjaA fusion Our data are rendered highly relevant by use of the target host in large numbers and support the potential of CjaA- and Peb1A-based vaccines for control of C. jejuni in poultry. (C) 2009 Elsevier Ltd All rights reserved

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available